FRINK Linked Data Fragments server

Matches in SemOpenAlex for { <https://semopenalex.org/work/W2372828405> ?p ?o ?g. }

• W2372828405 endingPage "100" @default.
• W2372828405 startingPage "1097" @default.
• W2372828405 abstract "To compare the therapeutic effect of one-stage direct revascularization and medicine therapy for the treatment of ischemic moyamoya disease.From March 2002 to March 2008, 18 patients with ischemic moyamoya disease (12 males and 6 females) were treated, aged 9 to 33 years old. Eighteen patients presented with ischemic stroke, including 11 cases of cerebral infarction and 7 cases of transient ischemic attack. According to Chinese ischemic cardiovascular diseases evaluation tools, 17 patients were classified as low risk ischemic stroke and 1 as moderate risk ischemic stroke. Different levels of occlusion branch of the intracranial carotid arteries and pathosis collaterals were identified by DSA. Fourteen patients and 4 patients were showed unilateral and bilateral hypoperfusion of cerebral blood flow by single photon emission computed tomography, respectively. Eleven patients received superficial temporal artery-middle cerebral artery anastomosis and 7 patients received medicine (anti-PLT agglutinin and calcium channel blocker).All incisions healed at stage I. There was no stroke events during perioperation. Anastomosis vessel vasospasm occurred in 2 patients 5 days after operation; and hyperperfusion syndrome in 1 patient 2 weeks after operation. All patients were followed up 13-32 months (mean 18 months). In 11 anastomosis patients, 6 underwent 6 stroke events within 12 months; in 7 medicine patients, 6 underwent 11 stroke events within 12 months; and showing a significant difference (P < 0.05). The stroke recurrence rate was 85.7% in medicine patients and 54.5% in anastomosis patients 12 months after therapy. DSA showed pathosis collaterals in 7 anastomosis patients and 6 medicine patients 6 months after therapy. After 12 months according to modified Rankin scale, the scores of anastomosis patients were 3 points in 1 case, 2 points in 6 cases and 0-1 point in 4 cases, and the scores of medicine patients were 2 points in 2 cases and 0-1 point in 5 cases; showing no significant difference (P > 0.05).As long as onset of stroke occurred and ischemic moyamoya disease is diagnosed, one-stage direct revascularization should be performed, which can reduce the rate of stroke recurrence risk and slow down the progression of disease." @default.
• W2372828405 created "2016-06-24" @default.
• W2372828405 creator A5005792320 @default.
• W2372828405 creator A5077055848 @default.
• W2372828405 date "2009-09-01" @default.
• W2372828405 modified "2023-10-18" @default.
• W2372828405 title "[Comparison of one-stage direct revascularization and medicine therapy for treatment of ischemic moyamoya disease]." @default.
• W2372828405 hasPubMedId "https://pubmed.ncbi.nlm.nih.gov/19817297" @default.
• W2372828405 hasPublicationYear "2009" @default.
• W2372828405 type Work @default.
• W2372828405 sameAs 2372828405 @default.
• W2372828405 citedByCount "1" @default.
• W2372828405 countsByYear W23728284052014 @default.
• W2372828405 crossrefType "journal-article" @default.
• W2372828405 hasAuthorship W2372828405A5005792320 @default.
• W2372828405 hasAuthorship W2372828405A5077055848 @default.
• W2372828405 hasConcept C126322002 @default.
• W2372828405 hasConcept C127413603 @default.
• W2372828405 hasConcept C141071460 @default.
• W2372828405 hasConcept C164705383 @default.
• W2372828405 hasConcept C2776548475 @default.
• W2372828405 hasConcept C2779450755 @default.
• W2372828405 hasConcept C2779464278 @default.
• W2372828405 hasConcept C2780645631 @default.
• W2372828405 hasConcept C500558357 @default.
• W2372828405 hasConcept C541997718 @default.
• W2372828405 hasConcept C71924100 @default.
• W2372828405 hasConcept C78519656 @default.
• W2372828405 hasConcept C8443397 @default.
• W2372828405 hasConceptScore W2372828405C126322002 @default.
• W2372828405 hasConceptScore W2372828405C127413603 @default.
• W2372828405 hasConceptScore W2372828405C141071460 @default.
• W2372828405 hasConceptScore W2372828405C164705383 @default.
• W2372828405 hasConceptScore W2372828405C2776548475 @default.
• W2372828405 hasConceptScore W2372828405C2779450755 @default.
• W2372828405 hasConceptScore W2372828405C2779464278 @default.
• W2372828405 hasConceptScore W2372828405C2780645631 @default.
• W2372828405 hasConceptScore W2372828405C500558357 @default.
• W2372828405 hasConceptScore W2372828405C541997718 @default.
• W2372828405 hasConceptScore W2372828405C71924100 @default.
• W2372828405 hasConceptScore W2372828405C78519656 @default.
• W2372828405 hasConceptScore W2372828405C8443397 @default.
• W2372828405 hasIssue "9" @default.
• W2372828405 hasLocation W23728284051 @default.
• W2372828405 hasOpenAccess W2372828405 @default.
• W2372828405 hasPrimaryLocation W23728284051 @default.
• W2372828405 hasRelatedWork W120020977 @default.
• W2372828405 hasRelatedWork W1993746075 @default.
• W2372828405 hasRelatedWork W2378358762 @default.
• W2372828405 hasRelatedWork W2384146240 @default.
• W2372828405 hasRelatedWork W2789757428 @default.
• W2372828405 hasRelatedWork W2790177585 @default.
• W2372828405 hasRelatedWork W2981349568 @default.
• W2372828405 hasRelatedWork W3030592560 @default.
• W2372828405 hasRelatedWork W3030721331 @default.
• W2372828405 hasRelatedWork W4212950122 @default.
• W2372828405 hasVolume "23" @default.
• W2372828405 isParatext "false" @default.
• W2372828405 isRetracted "false" @default.
• W2372828405 magId "2372828405" @default.
• W2372828405 workType "article" @default.